CDHA CAAR

A. “Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43)(Clinical Trial Optional),” (PAR-18-901, National Institute on Aging, in conjunction with other agencies, application deadlines November 13, 2018; November 12, 2019; November 13, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-18-901.htmlad

B. “Research Network on Telomeres as Sentinels of Environmental Exposures, Psychosocial Stress, and Disease Susceptibility (U24 Clinical Trial Not Allowed),” (RFA-AG-19-022, National Institute on Aging, in conjunction with other agencies, application deadline December 3, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-022.html

C. “Telomeres as Sentinels of Environmental Exposures, Psychosocial Stress, and Disease Susceptibility: A Methods Comparison Study (U01 Clinical Trial Optional),” (RFA-AG-19-023, National Institute on Aging, in conjunction with other agencies, application deadline December 3, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-023.html

“Clinical Trial on Effects of Statins in Older Adults without Clinical Cardiovascular Disease (U19 Clinical Trial Required),” (RFA-AG-19-020, National Institute on Aging, in conjunction with other agencies, application deadline December 17, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-020.html

A. “Alzheimer Centers for Discovery of New Medicines (U54 Clinical Trial Not Allowed),” (RFA-AG-19-010, National Institute on Aging, application deadline February 1, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-010.html

B. “Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Studies (Collaborative U01 Clinical Trial Not Allowed),” (RFA-HL-18-030, National Institute of Aging, in conjunction with other agencies, application deadlines Oct. 19, 2018). Note: There are three related funding announcement (follow the link under “Companion Funding Opportunity”): “Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 – Clinical Trial Required),” (RFA-HL-18-031); “Regenerative Medicine Innovation Project (RMIP) (UT2-Clinical Trial Not Allowed),” (RFA-HL-18-033); and, “Regenerative Medicine Innovation Project (RMIP) (U44 – Clinical Trial Not Allowed),” (RFA-HL-18-0″35).

grants.nih.gov/grants/guide/rfa-files/RFA-HL-18-030.html

C. “BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional),” (RFA-MH-19-135, National Institute on Aging, in conjunction with other agencies, application deadlines October 9, 2018; September 26, 2019 and September 28, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-135.html

D. “Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional),” (RFA-NS-18-041, National Institute on Aging, in conjunction with other agencies, application deadlines November 27, 2018; March 7, 2019; November 25, 2019; March 12, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-041.html

E. “Limited Competition: Renewal of, and Revisions to, the Alzheimer’s Disease Genetics Consortium (U01 Clinical Trial Not Allowed),” (PAR-18-889, a reissue of PAR-14-070, National Institute on Aging, application deadlines March 5, July 5, and Nov. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-889.html

F. “Limited Competition: Additional Sequencing for the Alzheimer’s Disease Sequencing Project: Opportunity for Revision Requests for Active Cooperative Agreements (U01 Clinical Trial Not Allowed),” (PAR-18-890, National Institute on Aging, in conjunction with other agencies, application deadlines March 5, July 5, and Nov. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-890.html

“Information and Planning: Understanding the Capacity of the Aging Network,” (HHS-2018-ACL-AOA-PPUC-0297, application deadline August 6, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=301901

“Grants for Early Medical/Surgical Specialists’ Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional),” (RFA-AG-19-021, a reissue of RFA-AG-18-015, National Institute on Aging, application deadline Oct. 23, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-021.html

A. “Late Stage Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01 Clinical Trial Required),” (PAR-18-878, a reissue of PAR-18-028, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-878.html

B. “Early Stage Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional),” (PAR-18-877, a reissue of PAR-18-175, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-877.html

A. “BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed),” (RFA-MH-19-146, a reissue of RFA-MH-17-256, National Institute on Aging, in conjunction with other agencies, application deadlines September 27, 2018 and September 6, 2019). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional),” (RFA-MH-19-145).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-146.html

B. “BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed),” (RFA-MH-19-147, National Institute on Aging, in conjunction with other agencies, application deadlines: September 27, 2018; March 7, 2019; September 6, 2019; March 6, 2020; September 9, 2020; March 4, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-147.html

A. “Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional),” (PA-18-849, a reissue of PA-18-134, National Institute on Aging, in conjunction with other agencies, applications deadline Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PA-18-849.html

B. “Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional),” (PA-18-850, a reissue of PA-18-153, National Institute on Aging, in conjunction with other agencies, applications deadline Feb. 16, June 16, and October 16).

grants.nih.gov/grants/guide/pa-files/PA-18-850.html

“Disaster Assistance for State Units on Aging (SUAs) and Tribal Organizations in National Disasters Declared by the President,” (HHS-2018-ACL-AOA-DASG-0237, application deadline Sept. 14, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=298224

“Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional),” (PA-18-849, a reissue of PA-18-134, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional),” (PA-18-850).

grants.nih.gov/grants/guide/pa-files/PA-18-849.html

“Information and Planning: Understanding the Capacity of the Aging Network,” (HHS-2018-ACL-AOA-PPUC-0297, application deadline August 6, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=301901

A. “NIA AD/ADRD Health Care Systems Research Collaboratory (U54 – Clinical Trial Required),” (RFA-AG-19-009, National Institute on Aging, application deadline September 6, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-009.html

B. “Integrative Omics to Enhance Therapeutics Development for Healthy Aging (UH2/UH3 Clinical Trial Not Allowed),” (RFA-AG-19-011, National Institute on Aging, application deadline November 14, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-011.html

C. “The National Health and Aging Trends Study (U01 Clinical Trial Not Allowed),” (RFA-AG-19-019, a reissue of RFA-AG-08-007, National Institute on Aging, application deadline October 1, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-019.html

A. “Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed),” (PA-18-837, National Institute on Aging, in conjunction with other agencies, Applications are accepted on a rolling basis at any time starting 30 days after the Open Date until the expiration date (Sept. 5, 2021)).

grants.nih.gov/grants/guide/pa-files/PA-18-837.html

B. “High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed),” (RFA-AG-19-015, National Institute on Aging, application deadline Feb. 1, 2019).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-015.html

C. “High-Priority Behavioral and Social Research Networks in Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (R24 Clinical Trial Not Allowed),” (RFA-AG-19-016, National Institute on Aging, application deadline Feb. 1, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-016.html

“Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional),” (PAR-18-835, a reissue of PAR-17-314, National Institute on Aging, in conjunction with other agencies, application due dates Nov. 7, 2018 and Nov. 7, 2019). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional),” (PAR-18-836).

grants.nih.gov/grants/guide/pa-files/PAR-18-836.html

“Strengthening the Financial Literacy & Preparedness of Family Caregivers,” (HHS-2018-ACL-AOA-FLFC-0309, application deadline August 10, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=306163

“Promoting Aging In Place by Enhancing Access to Home Modifications,” (HHS-2018-ACL-AOA-HMOD-0308, application deadline August 8, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=305883

A. “Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 – Clinical Trial Not Allowed),” (PA-18-823, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Exploratory Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R21 – Clinical Trial Not Allowed),” (PA-18-824).

grants.nih.gov/grants/guide/pa-files/PA-18-823.html

B. “Analyses of Adherence Strategies and Data Sets from CALERIE to Explore Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R01 – Clinical Trial Not Allowed),” (PA-18-825, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Exploratory Analyses of Adherence Strategies and Data Sets from CALERIE to Investigate Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R21 Clinical Trial Not Allowed),” (PA-18-826).

C. “Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional),” (PAR-18-820, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-822.html

D. “Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed),” (PA-18-817, National Institute on Aging, in conjunction with other agencies, application deadlines October 15, 2018; January 15, 2019; April 15, 2019; October 15, 2019; January 15, 2020; or April 15, 2020).

grants.nih.gov/grants/guide/pa-files/PA-18-817.html

E. “Roybal Centers for Translational Research on Aging (P30 – Clinical Trial Required),” (RFA-AG-19-006, a reissue of RFA-AG-14-004, National Institute on Aging, application deadline October 18, 2018). Note: There are two related funding announcement (follow the link under “Companion Funding Opportunity”): “Roybal Centers for Translational Research on Dementia Care Provider Support (P30 – Clinical Trial Required),” (RFA-AG-19-007); and, “Edward R. Roybal Coordinating Center (R24 – Clinical Trial Not Allowed),” (RFA-AG-19-008).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-006.html

F. “Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed),” (RFA-AG-19-017, a reissue of RFA-AG-18-006, National Institute on Aging, application deadline October 24, 2018). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Required),” (RFA-AG-19-018)

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-017.html

“Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional),” (PAR-18-820, a reissue of PAR-18-174, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-820.html

A. “BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Clinical Trial Required),” (PAR-18-813, National Institute on Aging, in conjunction with other agencies, first deadline for applications August 31, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-813.html

B. “BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed),” (PAR-18-814, National Institute on Aging, in conjunction with other agencies, first deadline for applications August 31, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-814.html

“Innovations in Nutrition Programs and Services,” (HHS-2018-ACL-AOA-INNU-0300, application deadline July 17, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=303333

A. “Collaborative Network to Advance Deprescribing Research for Older Adults with Multiple Chronic Conditions (R24 Clinical Trial Optional),” (RFA-AG-19-005, National Institute on Aging, application deadline October 18, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-005.html

B. “BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs – eTeamBCP (U01 Clinical Trial Not Allowed),” (RFA-NS-18-029, National Institute on Aging, in conjunction with other agencies, application deadlines July 23, 2018 and June 10, 2019).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-029.html

A. “Alzheimer’s Disease Programs to States and Communities,” (HHS-2018-ACL-AOA-ADPI-0307, deadline for applications July 16, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=305228

B. “National Alzheimer’s Call Center,” (HHS-2018-ACL-AOA-ADCC-0306, deadline for applications July 16, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=304497

A. “Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer’s Disease (AD) and Alzheimer’s Disease Related Dementias (ADRD) Research (R03 Clinical Trial Optional),” (RFA-AG-19-002, National Institute on Aging, in conjunction with other agencies, application deadline July 3, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-002.html

B. “Small Research Grant Program for the Next Generation of Researchers in Basic Alzheimer’s Disease (AD) and Alzheimer’s Disease Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed),” (RFA-AG-19-003, National Institute on Aging, in conjunction with other agencies, application deadline July 3, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-003.html

“Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional),” (PAR-18-747, National Institute on Aging, application deadlines June 14, 2018, November 14, 2018, June 14, 2019, November 14, 2019, June 15, 2020, November 13, 2020). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional),” (PAR-18-745).

grants.nih.gov/grants/guide/pa-files/PAR-18-747.html

A. “Geriatrics and Clinical Gerontology Research to Address Health Disparities in the U.S. (Admin Supp Clinical Trial Not Allowed),” (PA-18-751, National Institute on Aging, application due date July 16, 2018).

grants.nih.gov/grants/guide/pa-files/PA-18-751.html

B. “Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18),” (PA-18-750, Agency for Healthcare Research and Quality, application due dates Jan. 25, May 25, and Sept. 25).

grants.nih.gov/grants/guide/pa-files/PA-18-750.html

C. “Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed),” (PAR-18-749, National Institute on Aging, application due dates Jan. 25, May 25, and Sept. 25).

grants.nih.gov/grants/guide/pa-files/PAR-18-749.html

“Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional),” (PAR-18-740, is a reissue of PAR-17-254, National Institute on Aging, in conjunction with other agencies, application deadline August 31, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-740.html

“Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional),” (PA-18-738, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional),” (PA-18-739).

grants.nih.gov/grants/guide/pa-files/PA-18-738.html

“New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional),” (PAS-18-730, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAS-18-730.html

A. “Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional),” (PA-18-722, a reissue of PA-14-334, National Institute of Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional),” (PA-18-723).

grants.nih.gov/grants/guide/pa-files/PA-18-722.html

B. “Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional),” (PA-18-729, a reissue of PA-17-478, National Institute of Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional),” (PA-18-728).

grants.nih.gov/grants/guide/pa-files/PA-18-729.html

“NIA Limited Competition: Renewals of, and Revisions to, Existing Alzheimer’s Disease Patient Registry Cooperative Agreement Awards (U01 – Clinical Trial Not Allowed),” (PAR-18-715, National Institute on Aging, application deadlines Feb. 5, June 5, and October 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-715.html

A. “Native American Elder Justice Initiative,” (HHS-2018-ACL-AOA-IERC-0292, application deadline June 15, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=301902

B. “Information and Planning: Understanding the Capacity of the Aging Network,” (HHS-2018-ACL-AOA-PPUC-0297, application deadline June 18, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=301901

C. “National Alzheimer’s Call Center,” (HHS-2018-ACL-AOA-ACRC-0296, application deadline May 25, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=301900

“Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional),” (PA-18-713, a reissue of PA-17-098, National Institute on Aging, in conjunction with other agencies, application deadline May 7, 2018).

grants.nih.gov/grants/guide/pa-files/PA-18-713.html

A. “Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp),” (PA-18-713, a reissue of PA-17-098, National Institute on Aging, in conjunction with other agencies, application deadline May 7, 2018).

grants.nih.gov/grants/guide/pa-files/PA-18-713.html

B. “BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01-Clinical Trials Not Allowed),” (RFA-NS-18-019, a reissue of RFA-NS-17-004, National Institute on Aging, in conjunction with other agencies, application deadlines May 15, 2018, October 29, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-019.html

C. “BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed),” (RFA-NS-18-020, a reissue of RFA-NS-17-003, National Institute on Aging, in conjunction with other agencies, application deadlines May 15, 2018, October 29, 2018, May 1, 2019, October 29, 2019, May 1, 2020, and October 29, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-020.html

“Selective Cell and Network Vulnerability in Aging and Alzheimer’s Disease (R01 – Clinical Trial Not Allowed),” (PAR-18-706, a reissue of PAR-17-047, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-706.html

A. “Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54),” (RFA-OD-18-004, a reissue of RFA-OD-11-003, National Institute on Aging, in conjunction with other agencies, application deadline April 16, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-18-004.html

B. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33),” (PA-18-672, a reissue of PA-16-310, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-672.html

C. “Ruth L. Kirschstein National Research Service Award (NRSA)Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30),” (PA-18-673, a reissue of PA-16-306, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-673.html

A. “Pathway and Target Identification for Alzhiemer’s Disease Related Dementias (ADRDs) (U01 Clinical Trial Not Allowed),” (PAR-18-661, National Institute on Aging, in conjunction with other agencies, application deadline April 16, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-661.html

B. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31),” (PA-18-671, a reissue of PA-16-309, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-671.html

C. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32),” (PA-18-670, a reissue of PA-16-307, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-670.html

D. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30),” (PA-18-668, a reissue of PA-16-305, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-668.html

E. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31),” (PA-18-666, a reissue of PA-16-308, National Institute on Aging, in conjunction with other agencies, application deadlines Apr. 8, Aug. 8, and Dec. 8).

grants.nih.gov/grants/guide/pa-files/PA-18-666.html

F. “Administrative Supplement for Research on Sex/Gender Influences (Admin Supp – Clinical Trial Optional),” (PA-18-658, a reissue of PA-17-078, National Institute on Aging, in conjunction with other agencies, application deadline March 26, 2018).

grants.nih.gov/grants/guide/pa-files/PA-18-658.html

G. “Towards Implementing Novel Training Methods to Enhance Cognition in Aging (U01 Clinical Trial Required),” (RFA-AG-18-031, National Institute on Aging, application deadline April 30, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-031.html

A. “Alzheimer & Disease Initiative – Specialized Supportive Services (ADI-SSS) Project Financed Solely by 2018 Prevention and Public Health Funds (PPHF 2018),” (HHS-2018-ACL-AOA-ALGG-0284, application deadline June 18, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=300567

B. “Alzheimer & Disease Supportive Services Program (ADSSP): Creating and Sustaining Dementia-Capable Service Systems for People with Dementia and their Family Caregivers,” (HHS-2018-ACL-AOA-DS-0283, application deadline June 29, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=300566

A. “Dementia Care and Caregiver Support Interventions (R01 – Clinical Trial Required),” (RFA-AG-18-030, National Institute on Aging, application deadline April 10, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-030.html

B. “Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed),” (RFA-MD-18-006, National Institute on Aging, in conjunction with other agencies, application deadline April 16, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-MD-18-006.html

C. “Structural Biology of Alzheimer’s Disease Related Dementias (ADRDs) Proteinopathies (U01 Clinical Trial Not Allowed),” (RFA-NS-18-015, National Institute of Neurological Disorders and Stroke, application deadline April 30, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-015.html

D. “Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed),” (RFA-NS-18-024, National Institute on Aging, in conjunction with other agencies, application deadline April 17, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-024.html

E. “NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed),” (PA-18-648, National Institute on Aging, in conjunction with other agencies, application deadlines April 12, August 12, and Dec. 12).

grants.nih.gov/grants/guide/pa-files/PA-18-648.html

F. “Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required),” (PAR-18-630, a reissue of PAR-17-056, National Institute on Aging, in conjunction with other agencies, application deadlines April 10, 2018; December 7, 2018; March 7, 2019; December 7, 2019).

grants.nih.gov/grants/guide/pa-files/PAR-18-630.html

G. “Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 – Clinical Trial Optional),” (PAR-18-644, a reissue of PAR-16-368, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional),” (PAR-18-645).

grants.nih.gov/grants/guide/pa-files/PAR-18-644.html

“Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional),” (PAR-18-596, National Institute on Aging, in conjunction with other agencies, application deadline April 17, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-596.html

“Assistive Technology for Persons with Alzheimer’s Disease and Related Dementias and Their Caregivers (R41/R42 – Clinical Trials Optional),” (PAR-18-587, National Institute on Aging, application deadlines April 10, 2018, January 8, 2019, and January 8, 2020). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Assistive Technology for Persons with Alzheimer’s Disease and Related Dementias and Their Caregivers (R43/R44 – Clinical Trial Optional),” (PAR-18-588).

grants.nih.gov/grants/guide/pa-files/PAR-18-587.html

A. “Alzheimer’s Disease Research Centers (P30 – Clinical Trials Not Allowed),” (RFA-AG-19-001, a reissue of RFA-AG-16-018, National Institute on Aging, deadline for applications June 4, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-001.html

B. “Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed),” (PA-18-586, a reissue of PA-16-288, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-001.html

C. “Successor-in-Interest (Type 6 Parent Clinical Trial Optional),” (PA-18-589, a reissue of PA-16-286, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/pa-files/PA-18-589.html

D. “Change of Grantee Organization (Type 7 Parent Clinical Trial Optional),” (PA-18-590, a reissue of PA-16-285, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/pa-files/PA-18-590.html

E. “Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp – Clinical Trial Optional),” (PA-18-591, a reissue of PA-16-287, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/pa-files/PA-18-591.html

F. “Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp – Clinical Trial Not Allowed),” (PA-18-592, a reissue of PA-16-289, National Institute on Aging, in conjunction with other agencies).

grants.nih.gov/grants/guide/pa-files/PA-18-592.html

G. “Assistive Technology for Persons with Alzheimer’s Disease and Related Dementias and Their Caregivers (R43/R44 – Clinical Trial Optional),” (PAR-18-588, National Institute on Aging, application deadlines April 10, 2018, January 8, 2019, and January 8, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-18-588.html

“Pragmatic Trials for Dementia Care in Long-term Services and Support (LTSS) Settings (R61/R33 – Clinical Trial Required),” (PAR-18-585, a reissue of RFA-AG-17-065, National Institute on Aging, application deadlines March 27, 2018; February 20, 2019; and February 20, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-18-585.html

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required),” (PA-18-576, National Institute on Aging, in conjunction with other agencies, application deadlines Sept. 5, Jan. 5, and April 5). Note: There are three companion funding agreements (see links to the announcements under “Companion Funding Opportunity”): “PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed),” (PA-18-575); “PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed),” (PA-18-574); and, “PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required),” (PA-18-573).

grants.nih.gov/grants/guide/pa-files/PA-18-576.html

“Research to Evaluate Medication Management of Opioids and Benzodiazepines to Reduce Older Adult Falls,” (RFA-CE-18-004, application deadline March 23, 2018).

www.grants.gov/custom/viewOppDetails.jsp?oppId=297573

“Emotional Function in Normal Aging and/or MCI and AD/ADRD (R01 Clinical Trial Optional),” (PAR-18-581, National Institute on Aging, funding deadlines March 29, 2018; June 8, 2018; February 8, 2019; June 7, 2019; February 7, 2020; and June 8, 2020). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Emotional Function in Normal Aging and/or MCI and AD/ADRD (R21 Clinical Trial Not Allowed),” (PAR-18-582)

grants.nih.gov/grants/guide/pa-files/PAR-18-581.html

“Underactive Bladder and Detrusor Activity in Aging (R01 Clinical Trial Optional),” (PA-18-570, a reissue of PA-15-049, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 5, June 5, and Oct. 5). Note: There are two companion funding agreements (see links to the announcements under “Companion Funding Opportunity”): “Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional),” (PA-18-571); and, “Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional),” (PA-18-572).

grants.nih.gov/grants/guide/pa-files/PA-18-570.html

A. “Partnership for Aging and Cancer Research (U01 Clinical Trial Not Allowed),” (PAR-18-552, National Institute on Aging, in conjunction with other agencies, application deadline June 8, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-552.html

B. “Basic and Translational Research on Decision Making in Aging and Alzheimer’s Disease (R01 – Clinical Trial Optional),” (PAR-18-544, a reissue of PAR-16-448, National Institute on Aging, first application deadline March 29, 2018). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Basic and Translation Research on Decision Making in Aging and Alzheimer’s Disease (R21 – Clinical Trial Optional),” (PAR-18-538).

grants.nih.gov/grants/guide/pa-files/PAR-18-544.html

C. “Institutional Training Programs to Advance Translational Research on Alzheimer’s Disease and AD Related Dementias (T32 – Clinical Trial Not Allowed),” (PAR-18-524, a reissue of RFA-AG-17-063, National Institute on Aging, first application deadline March 29, 2018).

grants.nih.gov/grants/guide/pa-files/PAR-18-524.html

D. “Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 – Clinical Trial Optional),” (PA-18-545, a reissue of of PA-15-347, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PA-18-545.html

E. “Testing Lifespan-Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD) (R41/R42 Clinical Trial Not Allowed),” (PAR-18-514, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and April 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed),” (PAR-18-512).

grants.nih.gov/grants/guide/pa-files/PAR-18-514.html

F. “Sensory and motor system changes as predictors of preclinical Alzheimer’s disease (R01 – Clinical Trial Not Allowed),” (PAR-18-519, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-18-519.html

G. “Human Cell Biology of Alzheimer’s Disease Genetic Variants (R01 – Clinical Trial Not Allowed),” (PAR-18-516, a reissue of RFA-AG-17-053, National Institute on Aging, first application deadline March 29, 2018: other deadlines: June 8, 2018; October 9, 2018; February 8, 2019; June 7, 2019; October 7, 2019; February 7, 2020; June 7, 2020; and October 7, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-18-516.html

A. “2018 Empowering Older Adults and Adults with Disabilities through Chronic Disease Self-Management Education Programs Financed by the Prevention and Public Health Fund,” (HHS-2018-ACL-AOA-CSSG-0256, application deadline April 30, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=299734

B. “2018 Evidence-Based Falls Prevention Program financed by Prevention and Public Health Fund,” (HHS-2018-ACL-AOA-FPSG-0255, application deadline April 30, 2018).

www.grants.gov/web/grants/view-opportunity.html?oppId=299735

A. “Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required),” (PAR-18-513, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding agreement (see links to the announcements under “Companion Funding Opportunity”) related to this announcement: “Alzheimer’s Clinical Trials Consortium (ACTC) (U24),” (RFA-AG-17-005).

grants.nih.gov/grants/guide/pa-files/PAR-18-513.html

B. “Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional),” (PA-18-348, a reissue of PA-15-017, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There are two companion funding agreements (see links to the announcements under “Companion Funding Opportunity”): “Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed),” (PA-18-473); and, “Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R21 Clinical Trial Optional),” (PA 18-347).

grants.nih.gov/grants/guide/pa-files/PA-18-348.html

A. “Sleep disorders and circadian clock disruption in Alzheimers disease and other dementias of aging (R01 Clinical Trial Not Allowed),” (PAR-18-497, National Institute on Aging, application deadlines March 26, 2018, June 6, 2018; October 7, 2018; February 7, 2019; June 7, 2019; October 7, 2019; February 7, 2020; June 8, 2020; and October 8, 2020).

grants.nih.gov/grants/guide/pa-files/PAR-18-497.html

B. “Advancing the Science of Geriatric Palliative Care (R21 – Clinical Trial Optional),” (PA-18-503, a reissue of PA-17-226, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PA-18-503.html

C. “Advancing the Science of Geriatric Palliative Care (R01 – Clinical Trial Optional),” (PA-18-502, a reissue of PA-17-225, National Institute on Aging, in conjunction with other agences, application deadlines Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PA-18-502.html

D. “BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 – Clinical Trials Optional),” (RFA-NS-18-018, National Institute on Aging, in conjunction with other agencies, application deadlines February 23, 2018, June 6, 2018, October 4, 2018, February 6, 2019, June 4, 2019, October 4, 2019, February 6, 2020, June 4, 2020, and October 6, 2020).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-018.html

E. “BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 – Clinical Trials Not Allowed),” (RFA-NS-18-014, National Institute on Aging, in conjunction with other agencies, application deadlines March 15, 2018; July 17, 2018; July 15, 2019).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-014.html

F. “Deciphering the Molecular Landscape of Lung Aging in Humans (U01 – Clinical Trial Not Allowed),” (RFA-HL-19-012, National Heart, Lung, and Blood Institute, application deadline February 27, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-012.html

G. “From Association to Function in the Alzheimer’s Disease Post-Genomics Era (R01 – Clinical Trial Not Allowed),” (RFA-AG-18-026, a reissue of RFA-AG-17-010, National Institute on Aging, application deadline March 28, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-026.html

H. “Exosomes: From Biogenesis and Secretion to the Early Pathogenesis of Alzheimer’s Disease (R01 – Clinical Trial Not Allowed),” (RFA-AG-18-027, a reissue of RFA-AG-17-051, National Institute on Aging, application deadline March 26, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-027.html

I “Pragmatic Trials of Managing Multimorbidity in Alzheimer’s Disease (R01 Clinical Trial Required),” (RFA-AG-18-028, a reissue of RFA-AG-17-059, National Institute on Aging, application deadline March 26, 2017).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-028.html

J. “Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimer’s Disease Risk (R01 – Clinical Trial Not Allowed),” (RFA-AG-18-029, a reissue of RFA-AG-17-061, National Institute on Aging, application deadline March 26, 2018).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-029.html